Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 18323-44-9 Chemical Structure| 18323-44-9

Structure of Clindamycin
CAS No.: 18323-44-9

Chemical Structure| 18323-44-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Clindamycin inhibits protein synthesis by acting on the 50S ribosomal, used for the treatment of bacterial infections.

Synonyms: U-21251

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Clindamycin

CAS No. :18323-44-9
Formula : C18H33ClN2O5S
M.W : 424.98
SMILES Code : [C@]([H])([C@]1([H])[C@@H]([C@@H]([C@@H](O)[C@@H](SC)O1)O)O)([C@@H](Cl)C)NC([C@H]1N(C[C@H](CCC)C1)C)=O
Synonyms :
U-21251
MDL No. :MFCD00072005
InChI Key :KDLRVYVGXIQJDK-AWPVFWJPSA-N
Pubchem ID :446598

Safety of Clindamycin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H361
Precautionary Statements:P280-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00926367 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> cyberDERM Broomall, Pennsylvania, United States, 19008 Less <<
NCT01269541 Throatcarriers of MRSA Not Applicable Completed - Sweden ... More >> Helsingborg hospital Helsingborg, Skåne, Sweden Kristianstad hospital Kristianstad, Skåne, Sweden Infectious department SUS Lund Lund, Skåne, Sweden SUS Malmö Malmö, Skåne, Sweden Karolinska university hospital Stockholm, Sweden Örebro university hospital Örebro, Sweden Less <<
NCT00926367 - Completed - -
NCT01728363 Systemic Infection Phase 1 Completed - United States, Florida ... More >> University of FL Gainesville, Florida, United States, 32610 UFL Health and Baptist Jacksonville, Florida, United States, 32209 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Kansas Wesley Medical Wichita, Kansas, United States, 67214 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, New York Kings County Hospital Center Brooklyn, New York, United States, 11203 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Texas University of Texas Children's Hospital Galveston, Texas, United States, 77555 Less <<
NCT02446782 Pleural Effusion ... More >> Pleurisy Empyema Less << Phase 4 Completed - India ... More >> PGIMER Chandigarh, India, 160012 Less <<
NCT01016977 Acne Vulgaris Phase 4 Completed - -
NCT02545452 Endometriosis Phase 1 Completed - Germany ... More >> Berlin, Germany, 13353 Less <<
NCT01016977 - Completed - -
NCT01127880 Hemopneumothorax ... More >> Pneumothorax Less << Phase 2 Phase 3 Completed - United States, Pennsylvania ... More >> St. Luke's Hospital and Health Network Bethlehem, Pennsylvania, United States, 18015 Less <<
NCT01945450 Endometritis Not Applicable Unknown - Israel ... More >> Hadassah Medical Organization Not yet recruiting Jerusalem, Israel Less <<
NCT01125410 Bacterial Vaginosis Phase 3 Completed - Belgium ... More >> AZ Imelda Ziekenhuis Bonheiden, Belgium AZ St. Dimpna Geel, Belgium AZ Ziekenhuis Oost-Limburg Genk, Belgium AZ Heilig Hart Tienen, Belgium Czech Republic Centrum Ambulantni gynekologie a prodnictvi Brno, Czech Republic Faculty Hospital Brno Brno, Czech Republic University Hospital Hradec Kralove Hradec Kralove, Czech Republic Charles University Prague, Czech Republic Fakultni nemocnice Na Bulovce Prague, Czech Republic Ambulance pro gynekologie a prodnictvi Telc, Czech Republic Germany LMU Munich Munich, Germany Slovakia JLF UK a MFN Martin, Slovakia Switzerland University Hospital of Geneva and Faculty of Medicine Geneva, Switzerland CHUV Lausanne, Switzerland Less <<
NCT00730028 Staphylococcal Infection Phase 2 Completed - United States, California ... More >> San Francisco General Hospital - Infectious Diseases San Francisco, California, United States, 94110-3518 Harbor UCLA Medical Center - Medicine - Infectious Diseases Torrance, California, United States, 90502-2006 United States, Georgia Morehouse School of Medicine - Morehouse Medical Associates - Atlanta Atlanta, Georgia, United States, 30303-2544 United States, Illinois The University of Chicago - Comer Children's Hospital - Infectious Diseases Chicago, Illinois, United States, 60637-1425 United States, Missouri Washington University School of Medicine in St. Louis - Infectious Diseases Saint Louis, Missouri, United States, 63110-1010 United States, Tennessee Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States, 37232-2573 Less <<
NCT00398658 Endophthalmitis ... More >> Prophylaxy of Post Traumatic Endophthalmitis Bacterial Endophthalmitis Less << Phase 4 Completed - Iran, Islamic Republic of ... More >> Ophthalmic Research Center Tehran, Iran, Islamic Republic of, 16666 Less <<
NCT00642980 Pregnancy Phase 4 Completed - France ... More >> Hopital Jeanne de Flandre Lille, France, 59 000 Less <<
NCT01114516 Cervical Insufficiency Not Applicable Completed - United States, Illinois ... More >> Prentice Women's Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00730028 - Completed - -
NCT02731105 Acne Vulgaris Phase 4 Completed - Germany ... More >> Universitätsklinikum Carl Gustav Carus; Klinik und Poliklinik für Dermatologie Dresden, Saxony, Germany, 01307 Less <<
NCT01445301 - Completed - -
NCT01445301 Acne Vulgaris Phase 3 Completed - Japan ... More >> GSK Investigational Site Chiba, Japan, 273-0046 GSK Investigational Site Hokkaido, Japan, 002-8022 GSK Investigational Site Hokkaido, Japan, 003-0833 GSK Investigational Site Hokkaido, Japan, 004-0074 GSK Investigational Site Hokkaido, Japan, 004-0876 GSK Investigational Site Hokkaido, Japan, 006-0022 GSK Investigational Site Hokkaido, Japan, 060-0063 GSK Investigational Site Hokkaido, Japan, 062-0042 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 066-0021 GSK Investigational Site Hokkaido, Japan, 066-0064 GSK Investigational Site Hokkaido, Japan, 069-0813 GSK Investigational Site Hokkaido, Japan, 090-0832 GSK Investigational Site Hokkaido, Japan, 093-0016 GSK Investigational Site Kanagawa, Japan, 211-0063 GSK Investigational Site Kanagawa, Japan, 221-0825 GSK Investigational Site Osaka, Japan, 532-0026 GSK Investigational Site Osaka, Japan, 559-0017 GSK Investigational Site Osaka, Japan, 572-0838 GSK Investigational Site Osaka, Japan, 593-8324 GSK Investigational Site Saitama, Japan, 350-1305 GSK Investigational Site Tokyo, Japan, 111-0053 GSK Investigational Site Tokyo, Japan, 141-0031 GSK Investigational Site Tokyo, Japan, 150-0021 GSK Investigational Site Tokyo, Japan, 169-0075 GSK Investigational Site Tokyo, Japan, 194-0013 Less <<
NCT03122457 Actinic Keratosis Phase 2 Recruiting March 2019 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Giselle Singer, BS    212-241-3288    giselle.singer@mssm.edu    Contact: Anjali Shroff, MD    212-241-3288    Anjali.Shroff@mssm.edu    Principal Investigator: Anjali Shroff, MD Less <<
NCT03257202 Surgical Site Infection Phase 2 Completed - United States, California ... More >> Keck School of Medicine of the University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT01052246 Acne Vulgaris Not Applicable Completed - Germany ... More >> Laserklinik Karlsruhe Karlsruhe, Germany, D-76133 Less <<
NCT01114516 - Completed - -
NCT03742908 Breast Neoplasms Not Applicable Recruiting October 31, 2021 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Shanshan He    +86-22-23340123 ext 1174    ssh85@yahoo.com    Principal Investigator: Jian Yin Less <<
NCT03333408 Salivary Duct Phase 4 Recruiting November 2018 United States, Louisiana ... More >> Our Lady of the Lake Regional Medical Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Christine LeBoeuf, DNP    225-765-5956    christine.leboeuf@fmolhs.org Less <<
NCT01498744 - Terminated(The study was close... More >>d due to poor enrollment and lack of interest.) Less << - -
NCT00361322 Acne Vulgaris Phase 1 Phase 2 Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT01448733 Acne Vulgaris Phase 4 Unknown October 2011 United States, New York ... More >> Mt Sinai Hospital, Department of Dermatology New York, New York, United States, 10029 Less <<
NCT02399059 Colorectal Tumors Phase 3 Completed - -
NCT01498744 Abscess Soft Tissue ... More >> Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Skin Abscess Less << Not Applicable Terminated(The study was close... More >>d due to poor enrollment and lack of interest.) Less << - United States, Illinois ... More >> Ann and Robert H Lurie Children's Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00964223 Acne Vulgaris Phase 4 Completed - United States, Maryland ... More >> Aesthetics, Skin Care & Dermasurgery Rockville, Maryland, United States, 20850 United States, Michigan Grekin Skin Institute Warren, Michigan, United States, 48088 Less <<
NCT02348463 - Completed - -
NCT01378832 Surgical Site Infection Phase 3 Completed - -
NCT00000640 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - -
NCT00377000 Acne Vulgaris Phase 4 Completed - -
NCT00000674 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Stanford CRS Palo Alto, California, United States, 94304 Ucsd, Avrc Crs San Diego, California, United States, 92103 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 33136 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Cornell University A2201 New York, New York, United States, 10021 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 27599 Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States, 27710 United States, Pennsylvania Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00964223 - Completed - -
NCT00713609 - Completed - -
NCT01823523 Dentofacial Deformity Not Applicable Unknown October 2015 Canada, Nova Scotia ... More >> Victoria General Hospital Recruiting Halifax, Nova Scotia, Canada, B3H 1W2 Contact: Clayton Davis, DDS    902-473-2070    cmd@dal.ca Less <<
NCT00372294 Chorioretinitis Phase 3 Unknown November 2008 Iran, Islamic Republic of ... More >> Ophthalmic Research Center Tehran, Iran, Islamic Republic of, 16666 Less <<
NCT02210689 BACTERIAL VAGINOSIS ... More >> Signs and Symptoms to be Evaluated and Recorded Include: Vaginal Discharge: Color, Odor, and Consistency; Vulvovaginal Itching and Irritation (Subjective): Absent, Mild, Moderate, or Severe Vulvovaginal Inflammation (Objective): Absent, Mild, Moderate, or Severe. Less << Phase 3 Completed - United States, Alabama ... More >> Akesis Investigator site 5 Birmingham, Alabama, United States United States, California Akesis Investigator site 12 LA mesa, California, United States Akesis investigator site 6 San Diego, California, United States United States, Florida Akesis Investigator site 1 Boyton Beach, Florida, United States Akesis investigator site 14 North Miami, Florida, United States Akesis investigator site 17 Sanford, Florida, United States, 32771 Akesis investigator site 8 Sunrise, Florida, United States Akesis Investigator site 10 West Palm Beach, Florida, United States United States, Georgia Akesis Investigator site 9 Rosewell, Georgia, United States United States, Louisiana Akesis Investigator site 15 Metairie, Louisiana, United States United States, New Jersey Akesis investigator site 16 Lawrenceville, New Jersey, United States United States, New York Akesis investigator site 11 Port Jefferson, New York, United States United States, Pennsylvania Akesis investigator site 13 Philadephia, Pennsylvania, United States United States, Tennessee Akesis Investigator site 7 Jackson, Tennessee, United States United States, Texas Akesis investigator site 18 Houston, Texas, United States, 77011 Dominican Republic Akesis investigator site 3 Santo Domingo, Republica Dominicana, Dominican Republic Akesis investigator site 4 Santo Domingo, Republica Dominicana, Dominican Republic Puerto Rico Akesis Investigator site 2 Ponce, Puerto Rico Less <<
NCT02595034 Acne Vulgaris Phase 1 Completed - -
NCT00713609 Acne Vulgaris Phase 2 Completed - United States, Arkansas ... More >> Dermatology Research of Arkansas Little Rock, Arkansas, United States, 72205 United States, California Center for Dermatology Cosmetic and Laser Surgery Fremont, California, United States, 94538 Center for Dermatology and Laser Surgery Sacramento, California, United States, 95819 United States, Colorado Boulder Medical Center, P.C. Boulder, Colorado, United States, 80304 United States, Florida Dermatology Associates Research Coral Gables, Florida, United States, 33134 United States, Georgia MedaPhase, Inc. Newnan, Georgia, United States, 30263 United States, Maryland Callender Center for Clinical Research Mitchellville, Maryland, United States, 20721 United States, Michigan Grekin Skin Institute Warren, Michigan, United States, 48088 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27599 Dermatology Consulting Services High Point, North Carolina, United States, 27262 United States, Pennsylvania MS Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Tennessee Rivergate Dermatology & Skin Care Center Goodlettsville, Tennessee, United States, 37072 The Skin Wellness Center, PC Knoxville, Tennessee, United States, 37922 United States, Texas Dermatology Treatment & Research Center Dallas, Texas, United States, 75230 Suzanne Bruce and Associates, PA Houston, Texas, United States, 77056 Dermatology Clinical Research Center of San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01929278 Acne Vulgaris Phase 1 Completed - -
NCT01257906 MILD TO SEVERE ACNE VULGARIS Not Applicable Completed - India ... More >> Lotus Labs Pvt. Ltd Bangalore, India, 560 034 Less <<
NCT01867164 Vaginitis Inf... More >>ectious Vaginosis Less << Phase 3 Completed - Mexico ... More >> DF, Mexico Mexico D.F., Mexico Less <<
NCT01867164 - Completed - -
NCT00000717 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, Illinois Northwestern Univ Med School Chicago, Illinois, United States, 60611 Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ Hosp Indianapolis, Indiana, United States, 462025250 United States, Ohio Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland, Ohio, United States, 44106 Ohio State Univ Hosp Clinic Columbus, Ohio, United States, 432101228 Less <<
NCT01715610 Peritonsillar Abscess Not Applicable Withdrawn(unsuccessful recruit... More >>ment) Less << - Canada, Ontario ... More >> London Health Sciences Center, St. Joseph's Hospital London, Ontario, Canada, n5x4s1 Less <<
NCT00838812 Acne Vulgaris Phase 3 Completed - Brazil ... More >> Lal Clinica Valinhos, São Paulo, Brazil, 13276-245 Less <<
NCT00214643 Malaria Phase 3 Completed - Gabon ... More >> Medical Research Unit, Lambaréné Lambaréné, Moyen Ogooué, Gabon, B.P. 118 Less <<
NCT00889356 Candidiasis B... More >>acterial Vaginosis Less << Phase 3 Unknown March 2010 Brazil ... More >> Vox Femina Not yet recruiting Jundiaí, SP, Brazil Contact: Rogerio Bonassi Machado, MD          Principal Investigator: Rogerio Bonassi Machado, MD Less <<
NCT03267225 - Recruiting June 2019 France ... More >> Groupe Hospitalier Diaconesses Croix Saint Simon Recruiting Paris, France, 75020 Less <<
NCT00776919 - Completed - -
NCT01138514 Acne Vulgaris Phase 3 Completed - -
NCT01138514 - Completed - -
NCT02141217 Focal Infection, Dental Phase 4 Completed - Malaysia ... More >> GSK Investigational Site Kuala Lumpur, Malaysia, 50050 GSK Investigational Site Perak, Malaysia, 31350 GSK Investigational Site Putrajaya, Malaysia, 62250, GSK Investigational Site Selangor, Malaysia, 68100 Philippines GSK Investigational Site Cebu, Philippines, 6000 GSK Investigational Site Davao City, Philippines, 8000 GSK Investigational Site Quezon, Philippines, 1100 GSK Investigational Site Quezon, Philippines, 1109 Thailand GSK Investigational Site Lampang, Thailand, 52000 GSK Investigational Site Pranburi,, Thailand, 77120 GSK Investigational Site Songkhla, Thailand, 90112 Vietnam GSK Investigational Site Hanoi, Vietnam, Hoan Kiem District GSK Investigational Site Ho Chi Minh City, Vietnam, District 10 GSK Investigational Site Ho Chi Minh City, Vietnam, District 1 GSK Investigational Site Ho Chi Minh City, Vietnam, District 5 Less <<
NCT00776919 Acne Vulgaris Phase 3 Completed - -
NCT00671749 - Completed - -
NCT01796665 Acne Phase 3 Completed - -
NCT00964366 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> cyberDERM Broomall, Pennsylvania, United States, 19008 Less <<
NCT02141217 - Completed - -
NCT00964366 - Completed - -
NCT00671749 Acne Vulgaris Phase 4 Completed - United States, California ... More >> Center for Dermatology and Laser Surgery Sacramento, California, United States, 95819 United States, Kentucky Derm Research, P.L.L.C. Louisville, Kentucky, United States, 40217 United States, Ohio Brodell Medical Warren, Ohio, United States, 44483 United States, Oregon Northwest Cutaneous Research Specialists Portland, Oregon, United States, 97210 Less <<
NCT01293643 Vaginosis, Bacterial ... More >> Candidiasis, Vulvovaginal Less << Phase 3 Completed - -
NCT00217451 Malaria Phase 2 Completed - Gabon ... More >> Medical Research Unit, Lambaréné Lambaréné, Moyen Ogooué, Gabon, B.P. 118 Less <<
NCT00219570 Acne Vulgaris Phase 4 Completed - -
NCT01002183 Malaria Phase 2 Withdrawn(Drug combination is ... More >>no longer pursued) Less << - Thailand ... More >> Mahidol University Bangkok, Thailand, 10400 Less <<
NCT00911573 Skin Diseases ... More >> Infection Less << Phase 3 Withdrawn May 2014 -
NCT02465632 - Completed - -
NCT02593383 Acne Phase 1 Phase 2 Unknown March 2016 China, Jiangsu ... More >> Institute of Dermatology, Chinese Academy of Medical Sciences Recruiting Nanjing, Jiangsu, China, 210042 Contact: Heng GU, MD Less <<
NCT00352612 Staphylococcal Infection ... More >> Abscess Staphylococcal Skin Infection Folliculitis Less << Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT01047189 Acne Vulgaris Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences, Dermatology Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01047189 - Completed - -
NCT02465632 Acne Vulgaris Phase 3 Completed - United States, California ... More >> Glenmark Investigational Site 13 Anaheim, California, United States Glenmark Investigational Site 6 Long Beach, California, United States Glenmark Investigational Site 15 Los Angeles, California, United States Glenmark Investigational Site12 West Covina, California, United States United States, Florida Glenmark Investigational Site 4 Brandon, Florida, United States Glenmark Investigational Site 1 Miami, Florida, United States Glenmark Investigational Site 8 Miami, Florida, United States Glenmark Investigational Site 9 Miramar, Florida, United States Glenmark Investigational Site 2 Saint Petersburg, Florida, United States United States, Kentucky Glenmark Investigational Site 5 Louisville, Kentucky, United States United States, Pennsylvania Glenmark Investigational Site7 Upper Saint Clair, Pennsylvania, United States United States, South Carolina Glenmark Investigational Site 14 Greenville, South Carolina, United States United States, Tennessee Glenmark Investigational Site 3 Nashville, Tennessee, United States Belize Glenmark Investigational Site 10 Belize City, Belize Glenmark Investigational Site 11 Belize City, Belize Less <<
NCT02005666 Acne Vulgaris Phase 3 Completed - -
NCT01111994 Acne Phase 4 Unknown April 2010 United States, Maryland ... More >> Callender Center for Clinical Research Mitchellville, Maryland, United States, 20721 United States, Pennsylvania Society Hill Dermatology Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03717506 Acne Vulgaris Phase 3 Recruiting October 2019 -
NCT00823901 - Completed - -
NCT01915732 Acne Vulgaris Phase 3 Completed - China, Guangdong ... More >> GSK Investigational Site Guangzhou, Guangdong, China, 510010 GSK Investigational Site Guangzhou, Guangdong, China, 510080 GSK Investigational Site Guangzhou, Guangdong, China, 510120 China, Hebei GSK Investigational Site Wuhan, Hebei, China, 430071 China, Hunan GSK Investigational Site Changsha, Hunan, China, 410011 GSK Investigational Site Changsha, Hunan, China, 410013 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Nanjing, Jiangsu, China, 210042 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130041 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250022 China, Shanxi GSK Investigational Site Xian, Shanxi, China, 710032 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100020 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100036 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400038 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200032 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200092 GSK Investigational Site Shanghai, China, 200433 GSK Investigational Site Wuhan, China, 430022 Less <<
NCT00352612 - Completed - -
NCT03522441 Acne Vulgaris Phase 3 Recruiting November 28, 2018 United States, California ... More >> Site 11 Recruiting Encino, California, United States, 91436 Site 10 Recruiting Sherman Oaks, California, United States, 91403 United States, Florida Site 1 Recruiting Brandon, Florida, United States, 33511 Site 4 Recruiting Miramar, Florida, United States, 33027 Site 5 Recruiting Miramar, Florida, United States, 33027 Site 2 Recruiting Tampa, Florida, United States, 33069 Site 3 Recruiting Tampa, Florida, United States, 33618 United States, North Carolina Site 12 Recruiting High Point, North Carolina, United States, 27262 United States, Texas Site 8 Recruiting El Paso, Texas, United States, 79902 Site 9 Recruiting El Paso, Texas, United States, 79925 Belize Site 6 Recruiting Belize City, Belize Site 7 Recruiting Belize City, Belize Less <<
NCT01915732 - Completed - -
NCT01788384 Acne Vulgaris Phase 3 Completed - -
NCT01915758 Acne Vulgaris Phase 1 Completed - -
NCT00836056 - Completed - -
NCT00823901 Rosacea Phase 2 Phase 3 Completed - United States, California ... More >> Department of Dermatology - Stanford School of Medicine Stanford, California, United States, 94305 United States, Massachusetts CURTIS - Massachussetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00836004 - Completed - -
NCT02578043 Acne Vulgaris Phase 1 Completed - -
NCT00836004 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00836056 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT02058628 Acne Vulgaris Phase 4 Completed - Germany ... More >> GSK Investigational Site Stuttgart, Baden-Wuerttemberg, Germany, 70178 GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Augsburg, Bayern, Germany, 86179 GSK Investigational Site Gilching, Bayern, Germany, 82205 GSK Investigational Site Mahlow, Brandenburg, Germany, 15831 GSK Investigational Site Duelmen, Niedersachsen, Germany, 48249 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40212 GSK Investigational Site Dessau, Sachsen-Anhalt, Germany, 06847 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39120 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24148 GSK Investigational Site Berlin, Germany, 10783 Less <<
NCT02629770 - Recruiting December 2018 France ... More >> GH Diaconesses Croix Saint Simon Recruiting Paris, Ile de France, France, 75012 Contact: Valerie ZELLER, MD       vzeller@hopital-dcss.org Less <<
NCT02058628 - Completed - -
NCT01769664 Acne Vulgaris Phase 1 Completed - -
NCT03080740 Bacterial Vaginosis Phase 4 Recruiting December 2017 China ... More >> Peking University first hospital Recruiting Beijing, China, 100034 Contact: Zhaohui Liu, MD    +86-10-66174284 Less <<
NCT03374176 Periodontitis ... More >> Periodontal Pocket Diabetes Mellitus Less << Phase 3 Completed - -
NCT02314806 Breast Cancer Phase 3 Completed - -
NCT01769235 Acne Vulgaris Phase 1 Completed - -
NCT01697826 Vaginal Infections Phase 4 Completed - India ... More >> BJ Govt. Medical College & Sassoon General Hospitals, Pune Pune, Maharashtra, India, 411001 Less <<
NCT00837213 Acne Phase 4 Completed - United States, California ... More >> Center for Dermatology, Cosmetic and Laser Surgery Fremont, California, United States, 94538 United States, Nevada Las Vegas Skin & Cancer Clinic Las Vegas, Nevada, United States, 89129 Less <<
NCT01044264 Acne Vulgaris Not Applicable Completed - -
NCT01361269 Malaria Phase 2 Unknown December 2011 Gabon ... More >> Medical Research Unit, Albert Schweitzer Hospital Not yet recruiting Lambarene, Gabon Contact: Saadou Issifou    0024106106256    isaadou2002@yahoo.fr Less <<
NCT02616614 Acne Vulgaris Phase 3 Completed - United States, Arizona ... More >> Alliance Dermatology Phoenix, Arizona, United States, 85032 United States, California Estudy Chula Vista, California, United States, 91911 Estudy La Mesa, California, United States, 91942 United States, Florida Tampa Bay Medical Research Clearwater, Florida, United States, 33761 AMB Research Center Miami, Florida, United States, 33144 United States, Georgia Meridian Clinical Research Savannah, Georgia, United States, 31406 United States, Kansas Heartland Research Assoc Augusta, Kansas, United States, 67010 Heartland Research Assoc Wichita, Kansas, United States, 67207 United States, Missouri Sundance Clinical Research St. Louis, Missouri, United States, 63141 United States, Nebraska Meridian Clinical Research Norfolk, Nebraska, United States, 68701 Meridian Clinical Research Omaha, Nebraska, United States, 68134 United States, North Carolina Dermatology Consulting Services High Point, North Carolina, United States, 27262 United States, Ohio Sterling Research Group Cincinnati, Ohio, United States, 45246 United States, Texas Discover Research Beaumont, Texas, United States, 77701 DiscoverResearch Inc Bryan, Texas, United States, 77802 Reseacr Across America Dallas, Texas, United States, 75234 United States, Virginia Clinical Research Assoc. of Tidewater Norfolk, Virginia, United States, 23507 Less <<
NCT01015638 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> cyberDERM Broomall, Pennsylvania, United States, 19008 Less <<
NCT00837213 - Completed - -
NCT01464138 Malaria Phase 2 Completed - Mozambique ... More >> Centro de Investigacao em Saude da Manhica Maputo, Mozambique Less <<
NCT01015638 - Completed - -
NCT01500837 Osteoarticular Infection Not Applicable Completed - France ... More >> Assistance Publique Hopitaux de Paris Paris, France, 75015 Less <<
NCT03033472 Symptomatic Periapical Periodo... More >>ntitis Less << Phase 2 Phase 3 Not yet recruiting - -
NCT01422785 Acne Vulgaris Phase 4 Unknown - United States, New York ... More >> Mt Sinai Hospital - Dept of Dermatology Recruiting New York, New York, United States, 10029 Contact: Vicky Wong    212-241-3288       Principal Investigator: Joshua Zeichner, MD Less <<
NCT01876628 Cellulitis Phase 4 Unknown January 2016 United Kingdom ... More >> University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom, BS2 8HW Less <<
NCT01044264 - Completed - -
NCT02479971 Pain Phase 3 Completed - -
NCT02475876 Bacterial Infections Phase 1 Active, not recruiting May 30, 2019 United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Michigan University of Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT01619410 Skin Diseases, Bacterial ... More >> Abscess Less << Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT01800825 Pregnancy Pre... More >>maturity Preterm Birth Bacterial Vaginosis Less << Phase 4 Completed - India ... More >> Jawaharlal Nehru Medical College Belgaum, Karnataka, India Less <<
NCT01722708 Abnormal Vaginal Flora ... More >> Clindamycin Vs Metronidazole High Risk Pregnancies for Preterm Labor Less << Not Applicable Recruiting March 2020 Israel ... More >> Departement of obstetric and gynecology, HaEmek medical center Recruiting Afula, Israel Less <<
NCT02721173 Acne Vulgaris Phase 4 Completed - India ... More >> AIIMS, Bhubaneswar Bhubaneswar, Odisha, India, 751019 Less <<
NCT03234517 Bacterial Vaginosis Treatment Phase 2 Recruiting August 2018 Egypt ... More >> Zagazig University Recruiting Zagazig, Egypt Less <<
NCT01744730 Bacterial Infections|Obesity PHASE1 COMPLETED 2025-08-14 Ann and Robert H. Lurie Childr... More >>en's Hospital of Chicago, Chicago, Illinois, 60611, United States|Children's Mercy Hospital, Kansas City, Kansas, 64108, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Akron Children's Hospital, Akron, Ohio, 48109, United States Less <<
NCT02782078 Staphylococcal Infections Not Applicable Recruiting September 2018 France ... More >> Service de Médecine Interne - Hôpital Bichat Claude Bernard Recruiting Paris, France, 75018 Contact: Tiphaine Goulenok, MD    00 33 1 40 25 72 89    tiphaine.goulenok@aphp.fr Less <<
NCT01132443 Acne Vulgaris Phase 1 Completed - -
NCT03615768 Acne Vulgaris Phase 3 Recruiting June 2020 China, Jiangsu ... More >> Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences Recruiting Nanjing, Jiangsu, China, 210042 Contact: Yu Zhu       zhuyu@leespharm.com Less <<
NCT01744730 Bacterial Infections|Obesity PHASE1 COMPLETED 2025-08-14 Ann and Robert H. Lurie Childr... More >>en's Hospital of Chicago, Chicago, Illinois, 60611, United States|Children's Mercy Hospital, Kansas City, Kansas, 64108, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Akron Children's Hospital, Akron, Ohio, 48109, United States Less <<
NCT01819935 - Completed - -
NCT03269968 Obesity, Morbid ... More >> Wound Infection Wound Complication Less << Not Applicable Recruiting June 30, 2019 United States, District of Col... More >>umbia MedStar Washington Hospital Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Tetsuya Kawakita, MD       tetsuya.x.kawakita@medstar.net    Principal Investigator: Rachael Overcash, MD, MPH          Sub-Investigator: Sara Iqbal, MD          Sub-Investigator: Tetsuya Kawakita, MD Less <<
NCT02309346 Septic Abortion PHASE4 UNKNOWN 2025-12-19 Hospital de Clínicas de Porto ... More >>Alegre, Porto Alegre, Rio Grande Do Sul, 90035-003, Brazil Less <<
NCT00332163 Metastatic Colorectal Cancer ... More >> Skin Rash Skin Toxicities Colon Cancer Colorectal Cancer Less << Phase 2 Completed - -
NCT01400932 Acne Vulgaris Phase 3 Completed - Japan ... More >> GSK Investigational Site Kanagawa, Japan, 215-0036 GSK Investigational Site Kanagawa, Japan, 220-0004 GSK Investigational Site Kanagawa, Japan, 224-0001 GSK Investigational Site Kanagawa, Japan, 234-0051 GSK Investigational Site Kanagawa, Japan, 240-0013 GSK Investigational Site Kanagawa, Japan, 242-0007 GSK Investigational Site Osaka, Japan, 530-6012 GSK Investigational Site Osaka, Japan, 554-0021 GSK Investigational Site Saitama, Japan, 332-0031 GSK Investigational Site Tokyo, Japan, 102-0072 GSK Investigational Site Tokyo, Japan, 107-0062 GSK Investigational Site Tokyo, Japan, 116-0003 GSK Investigational Site Tokyo, Japan, 150-0047 GSK Investigational Site Tokyo, Japan, 157-0071 GSK Investigational Site Tokyo, Japan, 169-0075 GSK Investigational Site Tokyo, Japan, 180-0004 GSK Investigational Site Tokyo, Japan, 180-0023 GSK Investigational Site Tokyo, Japan, 190-0023 GSK Investigational Site Tokyo, Japan, 195-0053 Less <<
NCT02430246 Pregnancy Not Applicable Recruiting May 2020 Israel ... More >> HaEmek Medical Center Recruiting Afula, Israel Contact: ENAV YEFET, MD/PhD    +972-4-6494516    enavy1@gmail.com Less <<
NCT01908556 is to Identify Biomarkers That... More >> Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. Less << Phase 4 Unknown - Germany ... More >> Frauenklinik University Hospital Erlangen, Bavaria, Germany, 91054 Less <<
NCT02814916 Methicillin-Resistant Staphylo... More >>coccus Aureus Bacterial Infections Staphylococcal Skin Infections Less << Phase 3 Recruiting January 25, 2019 -
NCT03378427 Prosthetic Joint Infection Not Applicable Recruiting January 15, 2020 France ... More >> GHU Garches Recruiting Garches, France, 92380 Contact: Aurélien DINH, M.D.    +33 (0)1 47 10 77 58    aurelien.dinh@aphp.fr    Hôpital de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Tristan FERRY, M.D. Ph. D.    +33 (0)4 72 07 17 55    tristan.ferry@univ-lyon1.fr Less <<
NCT00332163 - Completed - -
NCT02538991 Urinary Stress Incontinence Not Applicable Active, not recruiting December 2022 Finland ... More >> Helsinki Women's Hospital Helsinki, Finland Less <<
NCT00827541 - Completed - -
NCT01400932 - Completed - -
NCT00827541 - Completed - -
NCT03466502 Clostridium Difficile Infectio... More >>n Less << Phase 4 Enrolling by invitation March 2019 United States, Nevada ... More >> Renown Regional Medical Center Reno, Nevada, United States, 89502 Less <<
NCT02366884 Neoplasms Phase 2 Enrolling by invitation December 31, 2020 United States, Maryland ... More >> Atavistic Chemotherapy Clinical Trial Bethesda, Maryland, United States, 20814 Mexico Dr. Frank Arguello Cancer Clinic San Jose del Cabo, Baja California Sur, Mexico Instituto de Ciencia y Medicina Genomica Torreon, Coahuila, Mexico Less <<
NCT02795845 Bacterial Vaginosis and Vagina... More >>l Candidiasis at Pregnancy Less << Not Applicable Recruiting September 2019 Israel ... More >> Departement of obstetric and gynecology, HaEmek medical center Recruiting Afula, Israel Contact: ENAV YEFET, MD/PhD    +972-4-6494516    enavy1@gmail.com    The holy family hospital Recruiting Nazareth, Israel Contact: Abeer Suliman, MD       abeersulim@gmail.com    Principal Investigator: Abeer Suliman, MD Less <<
NCT01819935 - Completed - -
NCT03402893 Acne Vulgaris ... More >> Post Inflammatory Hyperpigmentation Less << Phase 4 Completed - United States, Kentucky ... More >> DermResearch, PLLC Louisville, Kentucky, United States, 40217 Less <<
NCT03310333 PROM (Premature Rupture Of Foe... More >>tal Membrane) Less << Phase 4 Recruiting July 1, 2020 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Denis GALLOT Less <<
NCT01951768 Diabetic Foot Ulcer Phase 4 Unknown September 2015 Switzerland ... More >> Geneva University Hospitals Recruiting Geneva, Switzerland Contact: Ikler Uckay    41 22 372 33 11    Ilker.Uckay@hcuge.ch    Contact: Benjamin Kressmann       Benjamin.Kressmann@hcuge.ch    Principal Investigator: Ilker Uckay, MD Less <<
NCT03431701 Vaginal Scrubbing Not Applicable Recruiting February 2019 Lebanon ... More >> Makassed General Hospital Recruiting Beirut, Lebanon Contact: Manal Hubesih, MD    +9611636000 ext 6297    drmanalhubesihhusari@gmail.com Less <<
NCT02237586 Plasmodium Falciparum Malaria ... More >> Malaria Less << Phase 1 Completed - Gabon ... More >> Centre de Recherches Médicales de Lambaréné Lambaréné, Gabon, BP 118 Less <<
NCT02800785 Appendicitis Not Applicable Recruiting March 2021 United States, California ... More >> Olive View-UCLA Medical Center Recruiting Sylmar, California, United States, 91342 Contact: Anusha Krishnadasan       idnet@ucla.edu    Principal Investigator: David Talan, MD          Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Anusha Krishnadasan       idnet@ucla.edu    Principal Investigator: Amy Kaji, MD          United States, Colorado University of Colorado Denver Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Tracey MacDermott    303-724-2757    Tracey.MacDermott@ucdenver.edu    Principal Investigator: Lisa Ferrigno, MD          United States, Illinois Rush University Medical Center Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Saketh Nadimpalli    312-942-1735    saketh_nadimpalli@rush.edu    Principal Investigator: Thea Price, MD          United States, Iowa University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Cathy Fairfield    319-384-8335    catherine-fairfield@uiowa.edu    Principal Investigator: Brett Faine, PharmD, MS          United States, Maine Maine Medical Center Recruiting Portland, Maine, United States, 04102 Contact: Deb Burris    207-662-2467    burrid@mmc.org    Principal Investigator: Damien Carter, MD          United States, Massachusetts Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Melissa Griswold    617-414-6836    Melissa.griswold@bmc.org    Principal Investigator: Frederick Drake, MD          Principal Investigator: Sabrina Sanchez, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Ellie Rosseto    617-754-2332    erosseto@bidmc.harvard.edu    Principal Investigator: Nathan Shapiro, MD          United States, Michigan Michigan Medicine- University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Sinan Hanna    734-232-3813    sinanh@med.umich.edu    Principal Investigator: Hasan Alam, MD          Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Lillian Hayes    313-916-8006    lhayes4@hfhs.org    Principal Investigator: Jeffrey Johnson, MD          United States, Mississippi University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Deepti Patki    601-815-3008    dpatki@umc.edu    Principal Investigator: Alan Jones, MD          United States, New York New York University - Bellevue Hospital Active, not recruiting New York, New York, United States, 10016 New York University - Tisch Hospital Active, not recruiting New York, New York, United States, 10016 Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Lyn Goldsmith    212-342-0261    lg2240@cumc.columbia.edu    Principal Investigator: Katherine Fischkoff, MD          United States, Ohio The Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Kristina Zottola    614-292-7146    Kristina.Zottola@osumc.edu    Principal Investigator: Steven Steinberg, MD          United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Brittney Jackson    615-343-1980    Brittney.e.jackson@vanderbilt.edu    Principal Investigator: Wesley Self, MD          United States, Texas Lyndon B Johnson- Harris Health Recruiting Houston, Texas, United States, 77026 Contact: Debbie Lew, MPH    713-566-5097    debbie.f.lew@uth.tmc.edu    Principal Investigator: Mike K Liang, MD          The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77026 Contact: Garrett Jost       Garrett.B.Jost@uth.tmc.edu    Principal Investigator: Lillian Kao, MD          United States, Washington Providence Regional Medical Center Everett Recruiting Everett, Washington, United States, 98201 Contact: Tija Schmiesing, MHA    425-261-4075    Tija.Schmiesing@Providence.org    Principal Investigator: Careen Foster, MD          Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Erin Carney    206-685-9770    ecarney@uw.edu    Sub-Investigator: Heather L Evans, MD, MS          Sub-Investigator: Amber Sabbatini, MD, MPH          Virginia Mason University Village Medical Center Recruiting Seattle, Washington, United States, 98105 Contact: Adrian Parker    206-341-1021    Adrian.parker@virginiamason.org    Principal Investigator: Richard Thirlby, MD          Swedish Medical Center- First Hill Recruiting Seattle, Washington, United States, 98122 Contact: Julie Wallick    206-215-3986    Julie.Wallick@swedish.org    Principal Investigator: Katherine A Mandell, MD, MPH          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Erin Carney    206-685-9770    ecarney@uw.edu    Sub-Investigator: Giana H Davidson, MD, MPH          Sub-Investigator: Amber Sabbatini, MD, MPH          Madigan Army Medical Center Active, not recruiting Tacoma, Washington, United States, 98431 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.24mL

11.77mL

2.35mL

1.18mL

23.53mL

4.71mL

2.35mL

References

 

Historical Records

Categories